X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (90) 90
index medicus (64) 64
oncology (64) 64
isolated limb perfusion (59) 59
female (56) 56
male (52) 52
surgery (52) 52
middle aged (36) 36
aged (34) 34
animals (34) 34
melanoma (33) 33
cancer (32) 32
chemotherapy, cancer, regional perfusion - methods (31) 31
melphalan (31) 31
chemotherapy (29) 29
treatment outcome (28) 28
medicine & public health (25) 25
combined modality therapy (23) 23
adult (22) 22
tumor-necrosis-factor (21) 21
isolated pelvic perfusion (20) 20
retrospective studies (20) 20
health aspects (18) 18
antineoplastic agents - administration & dosage (17) 17
malignant-melanoma (17) 17
sarcoma (17) 17
chemotherapy, cancer, regional perfusion (16) 16
melanoma - pathology (15) 15
melanoma - therapy (15) 15
melphalan - administration & dosage (15) 15
neoplasm staging (15) 15
skin neoplasms - pathology (15) 15
isolated limb infusion (14) 14
regional chemotherapy (14) 14
melanoma - drug therapy (13) 13
mitomycin-c (13) 13
necrosis-factor-alpha (13) 13
survival rate (13) 13
adolescent (12) 12
analysis (12) 12
antineoplastic agents - therapeutic use (12) 12
cisplatin - administration & dosage (12) 12
follow-up studies (12) 12
perfusion (12) 12
surgical oncology (12) 12
tnf-alpha (12) 12
antineoplastic combined chemotherapy protocols - therapeutic use (11) 11
extremities (11) 11
hyperthermia, induced (11) 11
pelvic neoplasms - drug therapy (11) 11
prognostic-factors (11) 11
hematology, oncology and palliative medicine (10) 10
hyperthermia, induced - methods (10) 10
hypoxia (10) 10
melanoma - secondary (10) 10
metastasis (10) 10
prognosis (10) 10
prospective studies (10) 10
radiology, nuclear medicine & medical imaging (10) 10
skin neoplasms - drug therapy (10) 10
isolated hepatic perfusion (9) 9
pelvis (9) 9
aged, 80 and over (8) 8
balloon-occlusion technique (8) 8
carcinoma (8) 8
care and treatment (8) 8
interferon-gamma (8) 8
management (8) 8
melphalan - therapeutic use (8) 8
neoplasms - therapy (8) 8
pharmacokinetics (8) 8
rectal-cancer (8) 8
skin neoplasms - therapy (8) 8
stop-flow (8) 8
time factors (8) 8
tomography, x-ray computed (8) 8
tumors (8) 8
abridged index medicus (7) 7
antineoplastic agents, alkylating - therapeutic use (7) 7
antineoplastic combined chemotherapy protocols - administration & dosage (7) 7
colorectal-cancer (7) 7
drug therapy (7) 7
factor-alpha (7) 7
infusion (7) 7
melanoma - diagnosis (7) 7
metastases (7) 7
metastatic melanoma (7) 7
mitomycin - administration & dosage (7) 7
neoplasm recurrence, local - pathology (7) 7
phase-i (7) 7
physiology (7) 7
radiotherapy (7) 7
rats (7) 7
sarcoma - drug therapy (7) 7
sarcoma - therapy (7) 7
soft-tissue sarcoma (7) 7
survival analysis (7) 7
swine (7) 7
therapy (7) 7
ablation (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Melanoma Research, ISSN 0960-8931, 2017, Volume 27, Issue 5, pp. 439 - 447
Journal Article
Annals of Surgery, ISSN 0003-4932, 02/2012, Volume 255, Issue 2, pp. 281 - 286
Journal Article
Journal Article
BULLETIN DU CANCER, ISSN 0007-4551, 01/2009, Volume 96, Issue 1, pp. 103 - 109
Isolated pelvic perfusion (IPP) is a method of intra-arterial local-regional treatment using a simplified balloon occlusion technique. It achieved high-dose... 
STOP-FLOW | TNF-alpha | regional chemotherapy | PHASE-II | NECROSIS-FACTOR-ALPHA | TOXICITY | pelvic perfusion | ISOLATED LIMB PERFUSION | CHEMOTHERAPY | INTERFERON-GAMMA | ONCOLOGY | EXTREMITY | MELPHALAN | SOFT-TISSUE SARCOMA | surgery
Journal Article
International Journal of Clinical Oncology, ISSN 1341-9625, 10/2010, Volume 15, Issue 5, pp. 433 - 439
Journal Article
European Journal of Surgical Oncology, ISSN 0748-7983, 2005, Volume 31, Issue 8, pp. 897 - 904
To investigate the feasibility of hypoxic pelvic perfusion (HPP), using balloon catheter techniques as treatment modality for locally advanced pelvic... 
Balloon catheter | MMC | Phase I—II trial | Melphalan | Hypoxic perfusion | Pelvis | Stop-flow | Non-resectable pelvic tumours | ISOLATED HEPATIC PERFUSION | ABDOMINAL PERFUSION | hypoxic perfusion | melphalan | MESORECTAL EXCISION | pelvis | NECROSIS-FACTOR-ALPHA | STOP-FLOW TECHNIQUE | non-resectable pelvic tumours | UMCG Approved | CHEMOTHERAPY | phase I-II trial | LIMB PERFUSION | balloon catheter | COLORECTAL-CANCER | OCCLUSION TECHNIQUE | stop-flow | RECURRENT RECTAL-CANCER | Phase I-II trial | ONCOLOGY | Humans | Middle Aged | Antibiotics, Antineoplastic - adverse effects | Male | Tomography, X-Ray Computed | Melphalan - therapeutic use | Feasibility Studies | Pelvic Neoplasms - radiotherapy | Melphalan - adverse effects | Pelvic Neoplasms - drug therapy | Adult | Female | Neoadjuvant Therapy | Chemotherapy, Cancer, Regional Perfusion - methods | Mitomycin - adverse effects | Radiotherapy Dosage | Pelvic Neoplasms - surgery | Mitomycin - therapeutic use | Catheterization - methods | Survival Rate | Remission Induction | Antineoplastic Agents, Alkylating - therapeutic use | Magnetic Resonance Imaging | Antibiotics, Antineoplastic - therapeutic use | Aged | Antineoplastic Agents, Alkylating - adverse effects | Neoplasm Staging | Pain Measurement | Clinical trials | Medical equipment | Product development | Mitomycin | Physiological apparatus | Tumors
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 11/2017, Volume 18, Issue 11, p. 2382
Journal Article
Journal Article
Journal Article